191 related articles for article (PubMed ID: 12924704)
1. An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial.
Tatter SB; Shaw EG; Rosenblum ML; Karvelis KC; Kleinberg L; Weingart J; Olson JJ; Crocker IR; Brem S; Pearlman JL; Fisher JD; Carson K; Grossman SA;
J Neurosurg; 2003 Aug; 99(2):297-303. PubMed ID: 12924704
[TBL] [Abstract][Full Text] [Related]
2. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
3. The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective study.
Wernicke AG; Sherr DL; Schwartz TH; Pannullo SC; Stieg PE; Boockvar JA; Moliterno JA; Ivanidze J; Trichter S; Sabbas AM; Parashar B; Nori D
Brachytherapy; 2010; 9(1):91-9. PubMed ID: 19850535
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of a novel device for delivering brachytherapy to the margins of resected brain tumor cavities.
Stubbs JB; Frankel RH; Schultz K; Crocker I; Dillehay D; Olson JJ
J Neurosurg; 2002 Feb; 96(2):335-43. PubMed ID: 11838809
[TBL] [Abstract][Full Text] [Related]
5. GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.
Gabayan AJ; Green SB; Sanan A; Jenrette J; Schultz C; Papagikos M; Tatter SP; Patel A; Amin P; Lustig R; Bastin KT; Watson G; Burri S; Stea B
Neurosurgery; 2006 Apr; 58(4):701-9; discussion 701-9. PubMed ID: 16575334
[TBL] [Abstract][Full Text] [Related]
6. Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases.
Rogers LR; Rock JP; Sills AK; Vogelbaum MA; Suh JH; Ellis TL; Stieber VW; Asher AL; Fraser RW; Billingsley JS; Lewis P; Schellingerhout D; Shaw EG;
J Neurosurg; 2006 Sep; 105(3):375-84. PubMed ID: 16961129
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and safety of GliaSite brachytherapy in treatment of CNS tumors following neurosurgical resection.
Wernicke AG; Sherr DL; Schwartz TH; Pannullo SC; Stieg PE; Boockvar JA; Ivanidze J; Moliterno JA; Parashar B; Trichter S; Sabbas AM; Nori D
J Cancer Res Ther; 2010; 6(1):65-74. PubMed ID: 20479550
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and dosimetry of an aqueous solution containing sodium 3-(125I)iodo-4-hydroxybenzenesulfonate (Iotrex) for brachytherapy of resected malignant brain tumors.
Stubbs JB; Strickland AD; Frank RK; Simón J; McMillan K; Williams JA
Cancer Biother Radiopharm; 2000 Dec; 15(6):645-56. PubMed ID: 11190496
[TBL] [Abstract][Full Text] [Related]
9. Treatment of recurrent high-grade gliomas with GliaSite brachytherapy: a prospective mono-institutional Italian experience.
Gobitti C; Borsatti E; Arcicasa M; Roncadin M; Franchin G; Minatel E; Skrap M; Zanotti B; Tuniz F; Cimitan M; Capra E; Drigo A; Trovò MG
Tumori; 2011; 97(5):614-9. PubMed ID: 22158493
[TBL] [Abstract][Full Text] [Related]
10. Radiation safety considerations in GliaSite 125I brain implant procedures.
Strzelczyk J; Safadi R
Health Phys; 2004 May; 86(5 Suppl):S120-3. PubMed ID: 15069303
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and safety of outpatient brachytherapy in 37 patients with brain tumors using the GliaSite Radiation Therapy System.
Chino K; Silvain D; Grace A; Stubbs J; Stea B
Med Phys; 2008 Jul; 35(7):3383-8. PubMed ID: 18697562
[TBL] [Abstract][Full Text] [Related]
12. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma.
Mamelak AN; Rosenfeld S; Bucholz R; Raubitschek A; Nabors LB; Fiveash JB; Shen S; Khazaeli MB; Colcher D; Liu A; Osman M; Guthrie B; Schade-Bijur S; Hablitz DM; Alvarez VL; Gonda MA
J Clin Oncol; 2006 Aug; 24(22):3644-50. PubMed ID: 16877732
[TBL] [Abstract][Full Text] [Related]
13. Imaging after GliaSite brachytherapy: prognostic MRI indicators of disease control and recurrence.
Kleinberg L; Yoon G; Weingart JD; Parisi M; Olivi A; Detorie NA; Chan TA
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1385-91. PubMed ID: 19394153
[TBL] [Abstract][Full Text] [Related]
14. Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources.
Gutin PH; Leibel SA; Wara WM; Choucair A; Levin VA; Philips TL; Silver P; Da Silva V; Edwards MS; Davis RL
J Neurosurg; 1987 Dec; 67(6):864-73. PubMed ID: 3316532
[TBL] [Abstract][Full Text] [Related]
15. Experimental validation of dose calculation algorithms for the GliaSite RTS, a novel 125I liquid-filled balloon brachytherapy applicator.
Monroe JI; Dempsey JF; Dorton JA; Mutic S; Stubbs JB; Markman J; Williamson JF
Med Phys; 2001 Jan; 28(1):73-85. PubMed ID: 11213925
[TBL] [Abstract][Full Text] [Related]
16. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study.
Welsh J; Sanan A; Gabayan AJ; Green SB; Lustig R; Burri S; Kwong E; Stea B
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):159-65. PubMed ID: 17331666
[TBL] [Abstract][Full Text] [Related]
17. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
[TBL] [Abstract][Full Text] [Related]
18. Novel use of the Contura for high dose rate cranial brachytherapy.
Scanderbeg DJ; Alksne JF; Lawson JD; Murphy KT
Med Dosim; 2011; 36(4):344-6. PubMed ID: 21144735
[TBL] [Abstract][Full Text] [Related]
19. Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects.
McLendon RE; Akabani G; Friedman HS; Reardon DA; Cleveland L; Cokgor I; Herndon JE; Wikstrand C; Boulton ST; Friedman AH; Bigner DD; Zalutsky MR
Nucl Med Biol; 2007 May; 34(4):405-13. PubMed ID: 17499730
[TBL] [Abstract][Full Text] [Related]
20. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
